ABL Bio Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-88,431	-2,647	3,209	-43,558
Depreciation & Amortization	2,442	2,590	2,325	2,158
Loss (Gain) From Sale of Assets	0.34	2.64	-48	5.83
Loss (Gain) From Sale of Investments	-855.63	-1,132	592.13	-6,666
Stock-Based Compensation	3,657	6,001	4,382	7,521
Provision & Write-off of Bad Debts	-	-	-	-682.58
Other Operating Activities	41,932	-203.88	1,352	-15.18
Change in Unearned Revenue	-31,859	-31,859	63,562	-3,160
Change in Other Net Operating Assets	1,924	-1,113	-3,242	3,792
Operating Cash Flow	-71,189	-28,362	72,132	-40,605
Capital Expenditures	-10,210	-5,740	-2,055	-1,244
Sale of Property, Plant & Equipment	0.45	7.46	74.51	12
Cash Acquisitions	-	-	-21,256	-
Sale (Purchase) of Intangibles	-50.75	-104.41	-330.07	-21.4
Investment in Securities	64,096	35,941	-46,234	21,458
Other Investing Activities	33.64	-20.49	-196.46	17.62
Investing Cash Flow	53,669	29,884	-71,250	20,221
Long-Term Debt Issued	-	44,831	-	-
Long-Term Debt Repaid	-	-43,130	-1,091	-959.45
Net Debt Issued (Repaid)	1,718	1,701	-1,091	-959.45
Issuance of Common Stock	1,097	1,717	5,753	1,256
Other Financing Activities	-179.71	-1,981	-11.67	-12.36
Financing Cash Flow	142,635	1,437	4,649	284.13
Foreign Exchange Rate Adjustments	-2,192	-29.86	-1,984	1,030
Net Cash Flow	122,922	2,929	3,547	-19,070
Free Cash Flow	-81,400	-34,102	70,076	-41,850
Free Cash Flow Margin	-251.85%	-52.03%	104.12%	-784.87%
Free Cash Flow Per Share	-1699.73	-712.77	1473.24	-890.99
Cash Interest Paid	2,057	2,521	1,205	-
Cash Income Tax Paid	-	1,621	-2.6	-75.7
Levered Free Cash Flow	-66,231	-37,710	63,171	-
Unlevered Free Cash Flow	-66,099	-36,365	64,000	-
Change in Net Working Capital	27,235	32,186	-62,291	-

Source: S&P Capital IQ. Standard template. Financial Sources.